CDLX vs SRPT · rev $71.2M vs rev $1.13B
Cardlytics Inc (CDLX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Cardlytics Inc (CDLX) is a advertising agencies company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CDLX revenue for 2026-06-30 was $71.2M. Net income was -$19.4M. CDLX currently screens at market cap $95.0M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CDLX currently screens at market cap $95.0M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CDLX and SRPT stock pages for the full models.
Not investment advice.